Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Bella2017on Jun 02, 2017 3:56am

126 Views

Post# 26315082

RE:APHRIA: Biggest missed opportunity in Cannabis Sector

Well said Monteviale! ....and great customer service!

Monteviale wrote: By not investing in Aphria, you may be missing out on the biggest opportunity in the cannabis sector "globally".

Whats not to like about Aphria?

Early mover advantage.

Strongest management team in cannabis sector.

Only true commercial agricultural play in an expanding global market.

Well entrenched with Pharmaceutical Network.

Strong balance sheet and five quarters of profitability.

Low cost producer status.

Extremely well capitalized.

Fully funded 1,000,000 million sq. ft. of greenhouse space and growing.

250,000 sq. ft. of supporting infrastructure including bakery for future edible market.

Land banking in Leamington with the potential for an additional 3,000,000 sq. ft. of greenhouse space.

Potential for $2 Billion in Revenue from solely Leamington operation.

Expanding both domestically and internationally.

M